Biotech

All Articles

Vaxcyte rises on 'impressive' 31-valent PCV gain against Pfizer

.Vaxcyte introduced what experts called "magnificent" stage 1/2 records for its 31-valent pneumococc...

Recursion's brain health condition test reveals insufficient documentation of efficiency

.Recursion has stumbled with a very early exam of its tech-enabled strategy to medicine exploration,...

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Phone it a situation of excellent chemistry: Acepodia, a biotech based upon Nobel Prize-winning sci...

Praxis epilepsy medicine minimizes confiscations in phase 2 litigation

.Praxis Precision Medicines has racked up an additional midphase gain in epilepsy this year, with it...

Three officers surrender as Dyne posts blended data for DMD applicant

.After getting away a professional hold many years back, Dyne Rehab has actually shown brand new per...

Arrowhead fires off phase 3 information in unusual metabolic health condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its own hand before a possible face-off along with Ionis, p...

Pfizer, Valneva reveal lyme illness shot successful for second booster

.Pfizer as well as Valneva may have about 2 additional years to stand by before they help make the f...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Let's study a chat along with Ayla Ellison, Tough Biotech Managing Editor as well as Michelle Benz ...

New data show how Bayer's asundexian stopped working to prevent movements

.Bayer put on hold the phase 3 test for its own factor XIa prevention asundexian late last year afte...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its own several sclerosis (MS) med tolebrutinib to the FD...